Ponatinib Impurity 22 | CAS 1488423-79-5 - Request Quote
Ponatinib Impurity 22
| SZ CAT No: | SZ-P133032 |
| CAS No | 1488423-79-5 |
| Mol.F. | C16H13F3INO2 |
| Mol.Wt. | 435.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ponatinib Impurity 22 is chemically N-(4-(hydroxymethyl)-3-(trifluoromethyl)phenyl)-3-iodo-4-methylbenzamide. Ponatinib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Ponatinib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ponatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1488423-79-5
Purchase 1488423-79-5
Order 1488423-79-5
Enquire 1488423-79-5
price of 1488423-79-5
1488423-79-5 Supplier
1488423-79-5 Manufacturer
1488423-79-5 Exporter
buy high quality Ponatinib Impurity 22
Purchase Ponatinib Impurity 22
Ponatinib Impurity 22 suppliers
Ponatinib Impurity 22 manufacturers
Ponatinib Impurity 22 price
Order Ponatinib Impurity 22
Enquire Ponatinib Impurity 22
Ponatinib Impurity 22 cost
Ponatinib Impurity 22 Supplier
Ponatinib Impurity 22 Distributor
Ponatinib Impurity 22 for Method Validation
Ponatinib Reference Standard
Ponatinib Impurity 22 for ANDA Filing
Ponatinib Impurity 22 for Forced Degradation Studies
Ponatinib Impurity 22 Identification Standards
Ponatinib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.